Graypoint LLC’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$303K Sell
21,218
-5,627
-21% -$65.8K 0.02% 431
2025
Q1
$282K Buy
26,845
+1,256
+5% +$14.2K 0.02% 422
2024
Q4
$310K Sell
25,589
-6,400
-20% -$83.7K 0.02% 397
2024
Q3
$470K Buy
31,989
+5,250
+20% +$73.2K 0.03% 316
2024
Q2
$386K Sell
26,739
-782
-3% -$12.5K 0.03% 339
2024
Q1
$448K Sell
27,521
-6,990
-20% -$109K 0.03% 304
2023
Q4
$514K Sell
34,511
-5,062
-13% -$57.3K 0.04% 254
2023
Q3
$445K Sell
39,573
-9,000
-19% -$105K 0.04% 255
2023
Q2
$489K Buy
48,573
+8,847
+22% +$82.1K 0.05% 225
2023
Q1
$373K Buy
39,726
+11,787
+42% +$139K 0.04% 248
2022
Q4
$341K Buy
+27,939
New +$348K 0.04% 253

Other funds holding ELAN

Graypoint LLC's ELAN Position: Q2 2025 in Review

Graypoint LLC reduced its Elanco Animal Health (ELAN) stake by 21% in Q2 2025, selling an estimated $65.8K and leaving 21,218 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #431.

Graypoint LLC first reported a position in ELAN in Q4 2022 and has held it in 11 quarters since. The position peaked at $514K in Q4 2023. 367 funds tracked by Wall St. Rank hold ELAN as of Q2 2025.

  • Graypoint LLC held 21,218 shares of Elanco Animal Health worth $303K as of Q2 2025.
  • Graypoint LLC sold 5,627 Elanco Animal Health shares in Q2 2025, an estimated $65.8K.
  • Elanco Animal Health made up 0.02% of Graypoint LLC's portfolio in Q2 2025, its #431 holding.
  • Graypoint LLC first reported a position in Elanco Animal Health in Q4 2022 and has held it in 11 quarters since.
  • Graypoint LLC's Elanco Animal Health position peaked at $514K in Q4 2023.
  • 367 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.